Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Hypoaesthesia? 137 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Hypoaesthesia have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.4% of all adverse event reports for DABIGATRAN ETEXILATE.

137
Reports of Hypoaesthesia with DABIGATRAN ETEXILATE
0.4%
of all DABIGATRAN ETEXILATE reports
0
Deaths
56
Hospitalizations

How Dangerous Is Hypoaesthesia From DABIGATRAN ETEXILATE?

Of the 137 reports, 56 (40.9%) required hospitalization, and 8 (5.8%) were considered life-threatening.

Is Hypoaesthesia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 137 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Hypoaesthesia?

ADALIMUMAB (7,423) ETANERCEPT (4,497) METHOTREXATE (4,175) RITUXIMAB (3,605) TOFACITINIB (3,324) PREDNISONE (3,239) TOCILIZUMAB (3,238) FINGOLIMOD (3,180) LENALIDOMIDE (3,127) SECUKINUMAB (3,079)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Hypoaesthesia Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Hypoaesthesia Reports All Drugs Causing Hypoaesthesia DABIGATRAN ETEXILATE Demographics